...
首页> 外文期刊>International Journal of Pharmaceutics >Preparation of cubic-shaped sorafenib-loaded nanocomposite using well-defined poly(vinyl alcohol alt-propenylene) copolymer
【24h】

Preparation of cubic-shaped sorafenib-loaded nanocomposite using well-defined poly(vinyl alcohol alt-propenylene) copolymer

机译:使用明确定义的聚(乙烯醇ALT-丙烯)共聚物制备立方形索拉非苯甲酸纳米复合材料

获取原文
获取原文并翻译 | 示例
           

摘要

Vinyl alcohol (VA) copolymers having fine tunable polarities are emerging materials in drug delivery applications. VA copolymers rendering well-defined molecular architecture (C/OH ratio = 2, 4, 5 and 8) were used as carriers for model drug compound, fluorescein, which exhibited significantly different release characteristics depending on the polarity of the polymers. Based on the preliminary drug release tests the well-defined VA copolymer having C/OH = 5 ratio, poly(vinyl alcohol alt-propenylene) copolymer (PVA-5) was selected for nanocomposite synthesis. Sorafenib anticancer drug was embedded into PVA-5 (C/OH = 5 ratio) nanoparticles by nanoprecipitation resulting in nanoparticles exhibiting unusual cubic shape. The sorafenib-loaded nanocomposites showed continuous release during a day and concentration-dependant cytotoxicity on HT-29 cancer cells. This might be interpreted by the sustained release of the drug.
机译:具有微调极性的乙烯醇(VA)共聚物是药物递送应用中的新出现材料。 使定义明确的分子结构(C / OH比= 2,4,5和8)的VA共聚物用作模型药物化合物的载体,荧光素,这取决于聚合物的极性显着不同的释放特性。 基于初步药物释放试验,选择具有C / OH = 5比的明确定义的VA共聚物,聚(乙烯醇ALT-丙烯)共聚物(PVA-5)用于纳米复合物合成。 通过纳米沉淀,将索拉非尼抗癌药物嵌入PVA-5(C / OH = 5比率)纳米颗粒中,得到纳米颗粒表现出不寻常的立方形状。 加载的索拉芬纳米复合材料在白天和浓度依赖于HT-29癌细胞上的细胞毒性显示连续释放。 这可能会被药物的持续释放解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号